Detalhe da pesquisa
1.
Potassium homoeostasis and pathophysiology of hyperkalaemia.
Eur Heart J Suppl
; 21(Suppl A): A2-A5, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30837798
2.
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J
; 39(24): 2274-2281, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29126266
3.
Comprehensive efforts to increase adherence to statin therapy.
Eur Heart J
; 38(32): 2473-2479, 2017 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077470
4.
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(4): 406-419, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35092425
5.
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 85-99, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638977
6.
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 100-103, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463331
7.
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
Eur Heart J
; 36(40): 2677-80, 2015 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948737
8.
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 7(6): 557-567, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956964
9.
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Eur Heart J
; 35(35): 2383-431, 2014 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25086026
10.
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Eur J Anaesthesiol
; 31(10): 517-73, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127426
11.
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(3): 302-310, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180504
12.
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).
Eur J Anaesthesiol
; 27(2): 92-137, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20068416
13.
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.
Eur Heart J
; 30(22): 2769-812, 2009 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19713421
14.
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. / Wytyczne ESC/ESA dotyczace operacji niekardiochirurgicznych - ocena ryzyka sercowo-naczyniowego i postepowanie w 2014 roku.
Kardiol Pol
; 72(11): 857-918, 2014.
Artigo
em Polonês
| MEDLINE | ID: mdl-25524159